ADIL
NASDAQ · Pharmaceuticals
Adial Pharmaceuticals Inc
$1.81
+0.12 (+7.10%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+870.7% upside
Low Target
$13.09
Average Target
$17.57
High Target
$22.70
Current Price
$1.81
Current
$1.81
$1.81
Target
$17.57
$17.57
$13.09
$17.57 avg
$22.70
Scenario Analysis
Bear Case
$13.09
623.2%
Low target
Base Case
$17.57
+870.7%
Avg target
Bull Case
$22.70
+1,154.1%
High target
Risk/Reward
1.9x
Balanced
Price in Context
Target vs 52W High
$17.57
-97.4% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 39 | 77% | $1,330.33 | +45.2% |
| JNJ | Buy | 32 | 59% | $299.55 | +24.8% |
| MRK | Buy | 36 | 67% | $159.27 | +33.4% |
| PFE | Hold | 35 | 40% | $33.90 | +24.3% |
| BMY | Hold | 36 | 42% | $174.50 | +196.1% |
| ZTS | Buy | 25 | 64% | $209.87 | +79.8% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -22.9% |
| VTRS | Buy | 18 | 67% | $122.82 | +809.8% |